RELATIVE CARDIOVASCULAR AND GASTROINTESTINAL SAFETY OF NON-SELECTIVE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS VERSUS CYCLO-OXYGENASE-2 INHIBITORS: IMPLICATIONS FOR CLINICAL PRACTICE

PATRICIO, J.P., & BARBOSA, J.P.. (2013). RELATIVE CARDIOVASCULAR AND GASTROINTESTINAL SAFETY OF NON-SELECTIVE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS VERSUS CYCLO-OXYGENASE-2 INHIBITORS: IMPLICATIONS FOR CLINICAL PRACTICE. CLINICAL DRUG INVESTIGATION, 33(-), 167-183. SID. https://sid.ir/paper/625787/en

PATRICIO J.P., BARBOSA J.P.. RELATIVE CARDIOVASCULAR AND GASTROINTESTINAL SAFETY OF NON-SELECTIVE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS VERSUS CYCLO-OXYGENASE-2 INHIBITORS: IMPLICATIONS FOR CLINICAL PRACTICE. CLINICAL DRUG INVESTIGATION[Internet]. 2013;33(-):167-183. Available from: https://sid.ir/paper/625787/en

J.P. PATRICIO, and J.P. BARBOSA, “RELATIVE CARDIOVASCULAR AND GASTROINTESTINAL SAFETY OF NON-SELECTIVE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS VERSUS CYCLO-OXYGENASE-2 INHIBITORS: IMPLICATIONS FOR CLINICAL PRACTICE,” CLINICAL DRUG INVESTIGATION, vol. 33, no. -, pp. 167–183, 2013, [Online]. Available: https://sid.ir/paper/625787/en